Hopp til innhold
NHI.no
Annonse

Hepatitt, kronisk: Diagnostikk

Innhold i artikkelen

Mistanke om diagnosen får man ut i fra de aktuelle symptomene og eventuelle opplysninger om tidligere sykdommer. Videre vil legen gjennomføre en grundig kroppsundersøkelse. Ved langtkommen kronisk infeksjon vil det foreligge kroppslige tegn på leversvikt i form av små blodårenøster i huden (spider nevi), røde håndflater, forstørret lever og milt, gulsott, hudblødninger. 

Annonse

Blodprøver er viktige i utredningen og vil kunne avdekke tegn til sviktende leverfunksjon. Den endelige diagnosen stilles ut i fra en vevsprøve som tas med nål fra selve leveren. Ved fremskreden leversvikt kan det foreligge "froskebuk" (ascites) og risiko for alvorlige blødninger fra åreknuter i spiserøret.

Vil du vite mer

Dette dokumentet er basert på det profesjonelle dokumentet Hepatitt C . Referanselisten for dette dokumentet vises nedenfor

  1. Folkehelseinstituttet. Hepatitt C - veileder for helsepersonell. Sist oppdatert 02.04.2019. https
  2. Grebely J, Page K, Saks-Davis R. The effects of female sex, viral genotype, and IL28B genotype on spontaneous clearance of acute hepatitis C virus infection. Hepatology 2014; 69: 109. pmid:23908124 PubMed
  3. Den norske legeforening. Faglig veileder for oppfølging og behandling av hepatitt C hos voksne. 7. mars 2017. beta.legeforeningen.no
  4. Helsedirektoratet. Hepatitt C. Nasjonale faglige råd. Publisert april 2019. www.helsedirektoratet.no
  5. Dalgard O, Egeland A, Ervik R, et al. Risikofaktorer for hepatitt C-smitte blant sprøytemisbrukere. Tidsskr Nor Legeforen 2009; 129: 101-4. Tidsskrift for Den norske legeforening
  6. Bradshaw D, Matthews G, Danta M. Sexually transmitted hepatitis C infection: the new epidemic in MSM? Curr Opin Infect Dis 2013;26:66-72. PMID: 23242342 PubMed
  7. Vik IS, Skaug K, Dalgard O. Hepatitt C - et helseproblem også i Norge. Tidsskr Nor Legeforen 2008; 128: 563. Tidsskrift for Den norske legeforening
  8. WHO. Hepatitis C. Last updated 27 July 2020. www.who.int
  9. Moradpour D, Penin F. Hepatitis C proteins: from structure to function. Curr Top Microbiol Immunol 2013; 369: 113. pmid:23463199 PubMed
  10. Smith DG, Bukh J, Kuiken C. Expanded classification of hepatitis C virus into 7 genotypes and 67 subtypes: updated criteria and genotype assignment web resource. Hepatology 2014; 59: 318. pmid:24115039 PubMed
  11. Horner SM, Gale M. Intracellular Innate Immune Cascades and Interferon Defenses That Control Hepatitis C Virus. J Interferon Cytokine Res 2009; 9: 489. pmid:2956657 PubMed
  12. Lindenbach BD, Rice CM. Unravelling hepatitis C virus replication from genome to function. Nature 2005; 436: 933. pmid:16107832 PubMed
  13. Patel K, Muir AJ, McHutchison JG. Diagnosis and treatment of chronic hepatitis C infection. BMJ 2006; 332: 1013-7. PubMed
  14. Armstrong GL, Alter MJ, McQuillan GM. The past incidence of hepatitis C virus infection: implications for the future burden of chronic liver disease in the United States. Hepatology 2000; 3: 777. pmid:10706572 PubMed
  15. Thomas DL, Thio CL, Martin MP. Genetic variation in IL28B and spontaneous clearance of hepatitis C virus.. Nature 2009; 461: 798. pmid:19759533 PubMed
  16. Paintsil E, He H, Peters C, Lindenbach BD, Heimer R. Survival of hepatitis C virus in syringes: implcation for transmission among injection drug users. J Infect Dis 2010; 202: 984-90. PubMed
  17. Terrault NA, Dodge JL, Murphy EL. Sexual transmission of hepatitis C virus among monogamous heterosexual couples: the HCV partners study. Hepatology 2013; 57: 881. pmid:23175457 PubMed
  18. Witt MD, Saeberg EC, Darilay A. Incident hepatitis C virus infection in men who have sex with men: a prospective cohort analysis, 1984-2011. Clin Infect Dis 2013; 57: 77. pmid:23532480 PubMed
  19. Denniston MM, Jiles RB, Drobeniuc J, et al. Chronic hepatitis C virus infection in the United States, National Health and Nutrition Examination Survey 2003 to 2010. Ann Intern Med. 2014;160:293-300. PubMed
  20. Martinez-Bauer E, Forns X, Armellas M. Hospital admission is a relevant source of hepatitis C virus acquisition in Spain. J Hapatol 2008; 48: 20. pmid:17998149 PubMed
  21. Indolfi G, Resti M. Perinatal transmission og hepatitis C virus infection. JMed Virol 2009; 81: 836-43. PubMed
  22. Dalgard O, Konopski Z, Bosse FJ, et. al. Hepatitt C - utredning og behandling. Tidsskr Nor Legeforen 2011; 131: E1-8. Tidsskrift for Den norske legeforening
  23. Pembrey L, Newell ML, Tovo PA et al. The management of HCV infected pregnant women and their children European paediatric HCV network. J Hepatol 2005; 43: 515-25. PubMed
  24. Vanhommerig JW, Thomas XV, van der Meer JTM, et al. Hepatitis C virus (HCV) antibody dynamics following acute HCV infection and reinfection among HIV-infected men who have sex with men. Clin Infect Dis 2014; 59:1678. doi:10.1093/cid/ciu695
  25. Westbrook RH, Dusheiko G. Natural history of hepatitis C. J Hepatol. 2014;61(1 Suppl):S58–S68. PMID: 25443346 PubMed
  26. Calvaruso V, Cabibbo G, Cacciola I, et al. Incidence of hepatocellular carcinoma in patients with HCV-associated cirrhosis treated with direct-acting antiviral agents. Gastroenterology 2018. pmid:29655836 PubMed
  27. Nelson PK, Mathers BM, Cowie B, et al. Global epidemiology of hepatitis B and hepatitis C in people who inject drugs: results of systematic reviews. Lancet 2011; 378: 571-83. PubMed
  28. Aleman S, Rahbin N, Weiland O, et al. A risk for hepatocellular carcinoma persists long-term after sustained virologic response in patients with hepatitis C–associated liver cirrhosis. Clin Infect Dis 2013; 57: 230-6. doi:10.1093/cid/cit234
  29. Carrat F, Fontaine H, Dorival C, et al. Clinical outcomes in patients with chronic hepatitis C after direct-acting antiviral treatment: a prospective cohort study. Lancet 2019. pmid:30765123 PubMed
  30. Giordano TP, Henderson L, Landgren O, et al. Risk of non-Hodgkin lymphoma and lymphoprolierative precursor disease in UA veterans with hepatitis C virus. JAMA 2007; 297: 2010-7. Journal of the American Medical Association
  31. Pakpoor J, Noyce A, Goldacre R, et al. Viral hepatitis and Parkinson disease: A national record-linkage study. Neurology 2017. PMID: 28356465 PubMed
  32. Midgard H, Weir A, Palmateer N, et al. HCV epidemiology in high-risk groups and the risk of reinfection. J Hepatol. 2016;65(1 Suppl):S33–S45. PMID: 27641987 PubMed
Annonse
Annonse